Toxins News and Research

RSS

Not all congestion-producing chronic rhinosinusitis infections are the same

Rather, this problem that afflicts some 30 million Americans annually has four severity classifications that could help guide treatment today and help find better treatments in the future, says the lead author on the study published in the November issue of The Laryngoscope.

18 Nov 2004

Brain inflammation is a sign of autism

A new study by scientists at Johns Hopkins shows that brain inflammation is a sign of autism. The findings are reported in the online edition of Annals of Neurology, the scientific journal of the American Neurological Association.

15 Nov 2004

Discovery of new compounds that may treat mucus build-up associated with cystic fibrosis

Preliminary studies show these compounds improve the flow of mucus through the respiratory tract, allowing airways to clear more quickly and efficiently.

14 Nov 2004

BMA Cymru Wales to petition parliament to ban smoking in public places unless Wales goes smoke free within 10 months

BMA Cymru Wales is seriously considering the possibility of petitioning Parliament for a ban in public places in Wales using the rarely used private bills procedure.

14 Nov 2004

Women with arrhythmias may also benefit from implantable cardioverter-defibrillators

A small study of patients with heart failure not caused by blocked arteries indicates that women, as well as men, may benefit from implantable cardioverter-defibrillators (ICD), reported researchers at the American Heart Association’s Scientific Sessions 2004.

11 Nov 2004

Discovery of new gene that protects against lung cancer

Cancer Research UK scientists have discovered a new gene that protects against lung cancer, according to a study published in the journal PNAS.

9 Nov 2004

Neogen Europe have announced new tests to detect hazardous toxins in grains, wine, nuts and coffee

Neogen Europe Ltd. announced today the introduction of two new tests to detect hazardous toxins in grains, wine, nuts and coffee. Marketing has begun in Europe and the products will soon be available in the United States and other worldwide markets.

8 Nov 2004

VaxGen gets $877.5 million to supply 75 million doses of anthrax vaccine

VaxGen announced today that the U.S. government has awarded the company an $877.5 million contract to supply 75 million doses of anthrax vaccine for civilian defense.

4 Nov 2004

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.

21 Oct 2004

Discovery of fundamental mechanism within cells that link obesity and type 2 diabetes

Researchers from the Harvard School of Public Health have discovered what they believe is the fundamental mechanism within cells that links two fast-rising public health threats: obesity and Type 2 diabetes.

18 Oct 2004

Protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain

A protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain by transporting this agent back into the bloodstream, thus reducing the ability of this agent to reach tumors.

11 Oct 2004

A website set up by scientists for scientists aims to reduce the number of animals used in medical research

A website where scientists can share data and computer models of cells, organs and whole organisms has been set up by a researcher from the University of Bath to help reduce the number of animals used in medical research.

5 Oct 2004

New technique offers efficient blood cleansing

Blood poisoning is fatal in almost half of all cases. Patients could be helped by efficient blood cleansing. Scientists are working on a new technique that will quickly and effectively retrieve toxic substances from the vital fluid without altering the blood count.

4 Oct 2004

Scientists develop rapid-fire tests for botulinum toxin

Scientists at the University of Wisconsin-Madison have developed a pair of rapid-fire tests for botulinum toxin, a feat that could underpin new technologies to thwart bioterrorism and spur the development of agents to blunt the toxic action of the world's most poisonous substance.

29 Sep 2004

Researchers have decoded the genome of Legionella pneumophila, the bacteria responsible for Legionnaires' disease

Researchers at Columbia University Medical Center have decoded the genome of Legionella pneumophila, the bacteria responsible for Legionnaires' disease, and have found a few surprises in the bug's 3,000 genes.

28 Sep 2004

Research shows specific damage to nervous system in veterans with Gulf War syndrome

UT Southwestern researchers report that damage to the parasympathetic nervous system may account for nearly half of the typical symptoms - including gallbladder disease, unrefreshing sleep, depression, joint pain, chronic diarrhea and sexual dysfunction - that afflict those with Gulf War syndrome. Their findings will be published in the October issue of the American Journal of Medicine and are currently available online.

27 Sep 2004

Toxins News and Research

Not all congestion-producing chronic rhinosinusitis infections are the same

Brain inflammation is a sign of autism

Discovery of new compounds that may treat mucus build-up associated with cystic fibrosis

BMA Cymru Wales to petition parliament to ban smoking in public places unless Wales goes smoke free within 10 months

Women with arrhythmias may also benefit from implantable cardioverter-defibrillators

Discovery of new gene that protects against lung cancer

Neogen Europe have announced new tests to detect hazardous toxins in grains, wine, nuts and coffee

VaxGen gets $877.5 million to supply 75 million doses of anthrax vaccine

Bactericidal (bacteria-killing) versus bacteriostatic (bacteria-inhibiting) drugs for treating infections

Discovery of fundamental mechanism within cells that link obesity and type 2 diabetes

Protein called Mrp4 blocks the access of the anti-cancer drug topotecan into the brain

A website set up by scientists for scientists aims to reduce the number of animals used in medical research

New technique offers efficient blood cleansing

Scientists develop rapid-fire tests for botulinum toxin

Researchers have decoded the genome of Legionella pneumophila, the bacteria responsible for Legionnaires' disease

Research shows specific damage to nervous system in veterans with Gulf War syndrome

Chronic kidney disease increases a person's risk of heart disease, stroke, or death

Therapeutic hypothermia improves the chances of recovery among those who suffer from cardiac arrest

Scientist rewarded for breaking down transplant rejection

Researchers unravel genetic makeup of ticks to tackle disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News